Search for Clinical Trial Results

Sponsored By

Mastocytosis - 30 Studies Found

Status Study
Completed Study Name: Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Condition: Cutaneous Mastocytosis
Date: 2007-04-04
Interventions: Drug: TF 002
Recruiting Study Name: Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
Condition:
  • Urticaria Pigmentosa
  • Cutaneous Mastocytosis

Date: 2016-03-15
Interventions:
  • Other: skin biopsy A skin biop
Recruiting Study Name: A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Condition:
  • Smouldering Systemic Mastocytosis
  • Indolent Systemic Mastocytosis
  • Drug: masitinib (AB1010) masit
Terminated Study Name: Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
Condition:
  • Malignant Mast Cell Tumors
  • Solid Organ Sites

Date: 2012-06-07
Interventions: Other: QUALITY OF LIFE QUESTIONNAIRE QASICC AND EORTC QLQ-C30 ADMINISTRATION 30 DAYS AFTER CVC IMPLANTAT
Recruiting Study Name: Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
Condition: Systemic Mastocytosis
Date: 2015-05-05
Interventions: Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera
Completed Study Name: Natural History of Urticaria Pigmentosa in Children
Condition: Urticaria Pigmentosa
Date: 2007-04-30
Recruiting Study Name: Mast Cell Connect: A Registry for Patients With Mastocytosis
Condition: Mastocytosis
Date: 2015-11-19
Completed Study Name: The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
Condition: Mastocytosis
Date: 2009-07-20
Interventions: Drug: injections subcutaneous injections
Completed Study Name: Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
Condition: Systemic Mastocytosis
Date: 2007-03-19
Interventions: Drug: RAD001 (Everolimus) Oral RAD001 10 mg daily for 30 days
Completed Study Name: Imatinib in KIT-negative Systemic Mastocytosis
Condition: Systemic Mastocytosis
Date: 2011-02-16
Interventions: Drug: Imatinib Mesylate
  • In
Next >>>